Redwood City medical device maker Pulmonx boosts IPO targets by 69%
Pulmonx Corp., which makes minimally invasive medical devices for emphysema, on Wednesday said it hopes to raise about $210 million in its upcoming IPO — a boost of about 69% over previous targets.
The Redwood City company now plans to sell 10 million shares for between $17 and $18 a share, with about 1.5 million more shares set aside for underwriters. It previously planned to sell 6.7 million shares for between $14 and $16 each, with 1 million set aside for underwriters.
This is Pulmonx's second…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Cromwell Schubarth Source Type: news